Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

FSTR
Foster (Lb) Co
stock NASDAQ

At Close
Jul 27, 2026 3:59:54 PM EDT
42.20USD-0.472%(-0.20)63,413
36.48Bid   48.44Ask   11.96Spread
Pre-market
0.00USD-100.000%(-42.40)0
After-hours
Jul 27, 2026 4:00:30 PM EDT
42.31USD+0.261%(+0.11)8,386
OverviewOption ChainMax PainOptionsPrice & VolumeDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsTrends
FSTR Reddit Mentions
Subreddits
Limit Labels     

We have sentiment values and mention counts going back to 2017. The complete data set is available via the API.
Take me to the API
FSTR Specific Mentions
As of Jul 27, 2026 5:33:43 PM EDT (1 min. ago)
Includes all comments and posts. Mentions per user per ticker capped at one per hour.
83 days ago • u/Any_Pomegranate1134 • r/pennystocks • 05_may_2026_what_are_the_biggest_winners_and_why • 𝑺𝒕𝒐𝒄𝒌 𝑰𝒏𝒇𝒐 :stonk: • B
# Top Small-Cap Winners
1. **Cabaletta Bio (CABA)** — Up \~**30%** (to \~$3.83, market cap \~$426M)
* Biotech firm focused on CAR-T cell therapies (e.g., rese-cel for autoimmune diseases).
* **Why?** Recent positive momentum from clinical data presentations (ASGCT 2026), a major supply agreement with Cellares, and a $150M underwritten offering that apparently saw strong demand or was absorbed well (financing overhang addressed by analysts). High volume (\~29M shares).
2. **L.B. Foster (FSTR)** — Up \~**19%** (to \~$36.60, market cap \~$456M)
* Industrial/rail infrastructure company.
* **Why?** Strong Q1 2026 earnings beat: sales growth +23.9% YoY, EPS beat estimates significantly, profitability expansion, and reaffirmed full-year guidance. New 52-week high.
3. **Aura Biosciences (AURA)** — Up \~**19%** (market cap \~$638M)
* Clinical-stage biotech (precision therapies for solid tumors, e.g., eye cancer).
* **Why?** Positive updates on Phase 3 CoMpass trial enrollment acceleration, CEO transition to an experienced executive, and a large $260M public offering (priced at a level that supported buying interest amid clinical progress).
**Other notable movers** include biotech/pharma names on trial data or partnerships, and select industrials. Many small-cap gainers are in healthcare due to binary news events.
sentiment 0.99
83 days ago • u/Any_Pomegranate1134 • r/pennystocks • 05_may_2026_what_are_the_biggest_winners_and_why • 𝑺𝒕𝒐𝒄𝒌 𝑰𝒏𝒇𝒐 :stonk: • B
# Top Small-Cap Winners
1. **Cabaletta Bio (CABA)** — Up \~**30%** (to \~$3.83, market cap \~$426M)
* Biotech firm focused on CAR-T cell therapies (e.g., rese-cel for autoimmune diseases).
* **Why?** Recent positive momentum from clinical data presentations (ASGCT 2026), a major supply agreement with Cellares, and a $150M underwritten offering that apparently saw strong demand or was absorbed well (financing overhang addressed by analysts). High volume (\~29M shares).
2. **L.B. Foster (FSTR)** — Up \~**19%** (to \~$36.60, market cap \~$456M)
* Industrial/rail infrastructure company.
* **Why?** Strong Q1 2026 earnings beat: sales growth +23.9% YoY, EPS beat estimates significantly, profitability expansion, and reaffirmed full-year guidance. New 52-week high.
3. **Aura Biosciences (AURA)** — Up \~**19%** (market cap \~$638M)
* Clinical-stage biotech (precision therapies for solid tumors, e.g., eye cancer).
* **Why?** Positive updates on Phase 3 CoMpass trial enrollment acceleration, CEO transition to an experienced executive, and a large $260M public offering (priced at a level that supported buying interest amid clinical progress).
**Other notable movers** include biotech/pharma names on trial data or partnerships, and select industrials. Many small-cap gainers are in healthcare due to binary news events.
sentiment 0.99


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC